Preclinical targeting of NF-kappaB and FLT3 pathways in AML cells

Leukemia. 2008 Jul;22(7):1466-9. doi: 10.1038/sj.leu.2405102. Epub 2008 Jan 31.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / pathology
  • Mice
  • Mice, Inbred C57BL
  • NF-kappa B / antagonists & inhibitors*
  • Neoplastic Stem Cells / drug effects*
  • Pyrimidines / pharmacology*
  • fms-Like Tyrosine Kinase 3 / antagonists & inhibitors*

Substances

  • AS602868
  • NF-kappa B
  • Pyrimidines
  • FLT3 protein, human
  • fms-Like Tyrosine Kinase 3